Stentys SA (STNT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Stentys SA (STNT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6457
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Stentys SA (Stentys) is a medical device company that designs, develops and markets self-expanding stents for the treatment of patients with acute myocardial infarction and coronary disease. The company’s products include xposition S self-applying stent, mistent biodegradable sirolimus release stent and stentys AC thromboaspiration catheter. Its self apposing drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters to prevent the malapposition problems associated with conventional stents. Stentys conducts clinical program to demonstrate the safety and efficacy of its products. The company has operations in Germany, France, Italy, the Netherlands, Scandinavia, Poland, Spain and Switzerland. Stentys is headquartered in Paris, France.

Stentys SA (STNT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Stentys SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stentys SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Stentys SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stentys SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Stentys SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Stentys SA, Medical Equipment, Deal Details 10
Partnerships 10
Stentys Enters into Distribution Agreement with Micell for MiStent SES 10
Equity Offering 11
Stentys Raises USD14.6 Million in Rights Offering of Shares 11
Stentys Raises USD14.3 Million in Rights Offering of Shares 12
Stentys Announced Private Placement Of Shares 14
Stentys Completes Rights Issue Of Shares For US$47.3 Million 15
Stentys Completes Private Placement Of Shares For US$11 Million 16
Acquisition 17
Stentys Acquire Minvasys for USD9.2 Million 17
Stentys Completes Acquires Cappella Peel Away from Cappella for USD1.4 Million 18
Stentys SA – Key Competitors 19
Stentys SA – Key Employees 20
Stentys SA – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Oct 11, 2018: STENTYS: Financial Information for the Third Quarter of 2018 22
Apr 12, 2018: STENTYS: Financial Information for the First Quarter of 2018 23
Jan 08, 2018: STENTYS Reports Revenues for the Fourth Quarter and Full Year 2017 24
Oct 12, 2017: STENTYS: Revenues for the Third Quarter of 2017: Continued Growth for the Xposition S Stent 25
Oct 02, 2017: STENTYS: 2017 half-year results 26
Jul 12, 2017: STENTYS: Revenues Of €1.7 Million in the Second Quarter Of 2017 27
Apr 24, 2017: STENTYS Reports a 22% Increase in Revenues in the First Quarter of 2017 28
Jan 12, 2017: STENTYS: 2016 Annual Revenues up 20% at €7.3 Million 29
Corporate Communications 30
Apr 03, 2017: STENTYS is Strengthening Its Board by Co-Opting Two New Independent Members 30
Product News 31
May 24, 2017: STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Stentys SA, Medical Equipment, Key Facts, 2017 2
Stentys SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Stentys SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stentys SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Stentys SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stentys SA, Deals By Market, 2012 to YTD 2018 8
Stentys SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Stentys Enters into Distribution Agreement with Micell for MiStent SES 10
Stentys Raises USD14.6 Million in Rights Offering of Shares 11
Stentys Raises USD14.3 Million in Rights Offering of Shares 12
Stentys Announced Private Placement Of Shares 14
Stentys Completes Rights Issue Of Shares For US$47.3 Million 15
Stentys Completes Private Placement Of Shares For US$11 Million 16
Stentys Acquire Minvasys for USD9.2 Million 17
Stentys Completes Acquires Cappella Peel Away from Cappella for USD1.4 Million 18
Stentys SA, Key Competitors 19
Stentys SA, Key Employees 20
Stentys SA, Subsidiaries 21

List of Figures
Stentys SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Stentys SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Stentys SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Stentys SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Stentys SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stentys SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Stentys SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stentys SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Stentys SA (STNT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Strides Pharma Science Limited (STAR):医療機器:M&Aディール及び事業提携情報
    Summary Strides Pharma Science Limited (Strides Pharma), formerly Strides Shasun Ltd, is a pharmaceutical company which offers generic products. It focuses on the development and manufacture of intellectual property- led niche pharmaceutical products, over-the-counter drugs and nutraceuticals. The c …
  • Strongbridge Biopharma plc (SBBP)-製薬・医療分野:企業M&A・提携分析
    Summary Strongbridge Biopharma plc (Strongbridge), formerly Cortendo plc, is a commercial-stage biopharmaceutical company that develops and commercializes therapies for rare diseases. The company’s marketed product, KEVEYIS (dichlorphenamide), is indicated for the treatment of hyperkalemic, hypokale …
  • R-Biopharm AG:医療機器:M&Aディール及び事業提携情報
    Summary R-Biopharm AG (R-Biopharm), a subsidiary of Rohm Gmbh & Co KG, is a developer of test solutions for clinical diagnostics and food and feed analysis. The company offers test systems in the areas of infectological stool diagnostics, serological infection and allergy diagnostics for clinical di …
  • PVR Ltd:企業のM&A・事業提携・投資動向
    PVR Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PVR Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Matisa Materiel Industriel S.A.
    Matisa Materiel Industriel S.A. - Strategy, SWOT and Corporate Finance Report Summary Matisa Materiel Industriel S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Southern Maryland Electric Cooperative Inc:企業の戦略的SWOT分析
    Southern Maryland Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Sarovar Hotels Private Ltd:企業の戦略・SWOT・財務分析
    Sarovar Hotels Private Ltd - Strategy, SWOT and Corporate Finance Report Summary Sarovar Hotels Private Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Nova Eye Medical Ltd (EYE):企業の財務・戦略的SWOT分析
    Nova Eye Medical Ltd (EYE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Schroders Plc
    Schroders Plc - Strategy, SWOT and Corporate Finance Report Summary Schroders Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Borges International Group SLU:企業の戦略的SWOT分析
    Borges International Group SLU - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Transport for London:企業の戦略的SWOT分析
    Transport for London - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • RBC Bearings Inc (ROLL):企業の財務・戦略的SWOT分析
    Summary RBC Bearings Inc (RBC Bearings) is an equipment manufacturing company that deals with the production and distribution of engineered precision bearings and products. The company's industrial product portfolio include ball bearings, cam followers, collets and toolholders, pins, rollers, shafts …
  • Bone Therapeutics SA (BOTHE):医療機器:M&Aディール及び事業提携情報
    Summary Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. The company offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fracture …
  • Medinet Co Ltd (2370):製薬・医療:M&Aディール及び事業提携情報
    Summary Medinet Co Ltd (Medinet) is a regenerative medicine and cell therapy products developer. The company manufactures regenerative medical products and investigational products, and specified cell products. It provides somatic cell, somatic stem cell and induced pluripotent stem cell. Medinet pr …
  • SM Energy Company:企業の戦略・SWOT・財務分析
    SM Energy Company - Strategy, SWOT and Corporate Finance Report Summary SM Energy Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Agappe Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Agappe Diagnostics Ltd (Agappe) is an in vitro diagnostic company that manufactures clinical chemistry and immuno turbidimetry products. The company’s products categories include biochemistry, immunochemistry, serology, coagulation, hematology, system reagents, controls and calibrators; poin …
  • Cogstate Ltd (CGS):企業の財務・戦略的SWOT分析
    Summary Cogstate Ltd (Cogstate) is a cognitive assessment company that provides technology solutions. The company offers scientific consulting, precision recruitment and computerized assessment, among others. Its clinical trail solutions include computerized cognitive assessment, cogstate prescreen, …
  • Sino Oil and Gas Holdings Ltd (702):企業の財務・戦略的SWOT分析
    Summary Sino Oil and Gas Holdings Ltd (Sino Oil and Gas), formerly Genesis Energy Holdings Ltd, is an oil and gas company that offers production and development of oil properties. The company offers services such as oil and gas exploration, production, distribution, development and supplying service …
  • Gujarat State Petroleum Corp Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Gujarat State Petroleum Corp Ltd (GSPC) is a state owned vertically integrated energy company. The company carries out acquisition, exploration and development of oil and gas assets through its subsidiaries and associate companies. It has exploration assets in India. It also has interests in …
  • AECOM (ACM):企業の財務・戦略的SWOT分析
    AECOM (ACM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the poten …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆